Table 1.
Distribution of Isolates between Hospital and Community Associated Urinary Tract Infections Traparancy delavation
| Specimen Collection* | All UTI Isolates | Fluoroquinolone Resistant UTI Isolates | All UTI ESBL+ | Fluoroquinolone Resistant UTI ESBL+ | ||||
|---|---|---|---|---|---|---|---|---|
| N | % of Total | N | % of Total | N | % of Total | N | % of Total | |
| ≥48 hrs (HA) | 1476 | 38.4% | 454 | 40.7% | 255 | 47.8% | 170 | 44.6% |
| <48 hrs (CA) | 1488 | 38.7% | 413 | 37.0% | 180 | 33.8% | 140 | 36.8% |
| None Given | 881 | 22.9% | 249 | 22.3% | 98 | 18.4% | 71 | 18.6% |
| Total | 3845 | 1116 | 533 | 381 | ||||
| p-Value † | >0.05 | >0.05 | <0.001 | >0.05 | ||||
*
HA, hospital-associated; CA, community-associated.
†
>0.05, not statistically significant; <0.001, statistically significant (Fisher’s Exact Test, two-tailed).